bibliographic resource 408804 [br/408804]
https://w3id.org/oc/corpus/br/408804
- is a
-
- title
-
- Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-